華廣生技股份有限公司
華廣生技股份有限公司（Bionime Corporation）設計、製造與銷售醫療儀器。主要製造血糖監測儀與測試片，提供給醫材公司、藥局及醫院。以「RIGHTEST」品牌行銷血糖管理系統，並開發連續血糖監測系統（CGM）。此外涉及精準儀器銷售。公司成立於 2003 年，總部位於台灣台中。
今日下跌 2.76%，股價跌破短期均線。該股 RSI(6) 為 32.7，處於中性區間，短線無明顯超買超賣訊號。股價跌破5日、20日、60日、120日均線。短中期均線呈多頭排列，趨勢偏多。KD 指標中性（K=65.8）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | -19 | 0 | 0 | -19 |
| 09-23 | -12 | 0 | 0 | -12 |
| 09-22 | +9 | 0 | 0 | +9 |
| 09-21 | +4 | 0 | +1 | +5 |
| 09-18 | +6 | 0 | +1 | +7 |
| 09-17 | +8 | 0 | 0 | +8 |
| 09-16 | +16 | 0 | -35 | -19 |
| 09-15 | -18 | 0 | 0 | -18 |
| 09-14 | +1 | 0 | 0 | +1 |
| 09-11 | -10 | 0 | 0 | -10 |
| 09-10 | -17 | 0 | 0 | -17 |
| 09-09 | -3 | 0 | 0 | -3 |
| 09-08 | -5 | 0 | 0 | -5 |
| 09-07 | +42 | 0 | 0 | +42 |
| 09-04 | +58 | 0 | 0 | +58 |
| 09-03 | -2 | 0 | 0 | -2 |
| 09-02 | +1 | 0 | 0 | +1 |
| 09-01 | +2 | 0 | 0 | +2 |
| 08-31 | +2 | 0 | 0 | +2 |
| 08-28 | +42 | 0 | 0 | +42 |
| 08-27 | +11 | 0 | 0 | +11 |
| 08-26 | +22 | 0 | +2 | +24 |
| 08-25 | +16 | 0 | 0 | +16 |
| 08-24 | +5 | 0 | 0 | +5 |
| 08-21 | +8 | 0 | 0 | +8 |
| 08-20 | +12 | 0 | 0 | +12 |
| 08-19 | +1 | 0 | 0 | +1 |
| 08-18 | +26 | 0 | 0 | +26 |
| 08-17 | +18 | 0 | 0 | +18 |
| 08-14 | -24 | 0 | 0 | -24 |
| 08-13 | +42 | 0 | +1 | +43 |
| 08-12 | +32 | 0 | 0 | +32 |
| 08-11 | +36 | 0 | 0 | +36 |
| 08-10 | +27 | 0 | 0 | +27 |
| 08-07 | +19 | 0 | 0 | +19 |
| 08-06 | -25 | 0 | -1 | -26 |
| 08-05 | +13 | 0 | 0 | +13 |
| 08-04 | +2 | 0 | -5 | -3 |
| 08-03 | -35 | 0 | -1 | -36 |
| 07-31 | -22 | 0 | 0 | -22 |
| 07-30 | +13 | 0 | -13 | 0 |
| 07-29 | +84 | 0 | +1 | +85 |
| 07-28 | +27 | 0 | +15 | +42 |
| 07-27 | +4 | 0 | 0 | +4 |
| 07-24 | +5 | 0 | 0 | +5 |
| 07-23 | -13 | 0 | 0 | -13 |
| 07-22 | -9 | 0 | -7 | -16 |
| 07-21 | -24 | 0 | -5 | -29 |
| 07-20 | -7 | 0 | +3 | -4 |
| 07-17 | +2 | 0 | -5 | -3 |
| 07-16 | -52 | 0 | -18 | -70 |
| 07-15 | -67 | 0 | -7 | -74 |
| 07-14 | +2 | 0 | -21 | -18 |
| 07-13 | -7 | 0 | +21 | +14 |
| 07-09 | +23 | 0 | -1 | +22 |
| 07-08 | +8 | 0 | -1 | +7 |
| 07-07 | +3 | 0 | +2 | +5 |
| 07-06 | -31 | 0 | 0 | -31 |
| 07-03 | +51 | 0 | 0 | +51 |
| 07-02 | +8 | 0 | 0 | +8 |
| 07-01 | +45 | 0 | 0 | +45 |
| 06-30 | -25 | 0 | 0 | -25 |
| 06-29 | +14 | 0 | 0 | +14 |
| 06-26 | -57 | 0 | -2 | -59 |
| 06-25 | -26 | 0 | +1 | -25 |
| 06-24 | +78 | 0 | -1 | +77 |
| 06-22 | -1 | 0 | 0 | -1 |
| 06-18 | -15 | 0 | 0 | -15 |
| 06-17 | -12 | 0 | +1 | -11 |
| 06-16 | -20 | 0 | -1 | -21 |
| 06-15 | -21 | 0 | +2 | -19 |
| 06-12 | -26 | 0 | 0 | -26 |
| 06-10 | -9 | 0 | -1 | -10 |
| 06-09 | -7 | 0 | 0 | -7 |
| 06-08 | -38 | 0 | +1 | -37 |
| 06-04 | +8 | 0 | +2 | +10 |
| 06-03 | -21 | 0 | -2 | -23 |
| 06-02 | -7 | 0 | -1 | -8 |
| 06-01 | +10 | 0 | -1 | +9 |
| 05-29 | +5 | 0 | 0 | +5 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/08 | 1.50 億 | +2.9% | -10.3% |
| 2026/07 | 1.46 億 | +1.5% | +2.4% |
| 2026/06 | 1.44 億 | +1.4% | -6.5% |
| 2026/05 | 1.42 億 | +0.3% | -13.4% |
| 2026/04 | 1.41 億 | -15.6% | -8.4% |
| 2026/03 | 1.67 億 | +51.5% | +4.7% |
| 2026/02 | 1.11 億 | -13.1% | -28.9% |
| 2026/01 | 1.27 億 | -20.9% | -23.3% |
| 2025/12 | 1.61 億 | +25.0% | +12.8% |
| 2025/11 | 1.29 億 | -6.3% | -29.1% |
| 2025/10 | 1.37 億 | -7.8% | -22.8% |
| 2025/09 | 1.49 億 | - | -8.1% |